Trial
NCT02076243
Treatment With Nab-paclitaxel in Cutaneous SCC
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
Celgene Corporation
Condition
Cutaneous Squamous Cell Carcinoma
Intervention
nab-paclitaxel
Why stopped
Closed by sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-25